We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Synthetic Biologics Inc | AMEX:SYN | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.02 | 0 | 00:00:00 |
RNS Number:3830J Synstar PLC 31 March 2003 31 March 2003 Synstar Plc ("Synstar") Ahead of entering its close period, Synstar, the pan-European IT services provider, is today updating the market on trading for the six month period ended 31 March 2003. We are pleased to confirm that current trading continues in line with market expectations. We continue to make progress cross-selling our services into current customers with recent examples at Avecia, London Electricity and First Group. Additionally our efforts in new name sales have been rewarded with new contract wins including Cognotec and Atomic Weapons Establishment. Our plans for the recovery of our French business remain on track and feature the signing of several multi-service line deals, for example, with CORSAIR. Our order book remains strong, benefiting from regularly winning larger, more ' joined up' deals. We continue to adjust our mix of services, exiting under-performing contracts in order to maintain upward pressure on overall margins. The Board remains confident that Synstar's flexible and innovative approach to its customers' end to end IT requirements, coupled with continuing excellent customer satisfaction results, means the Group is well placed to deliver enhanced profitability going forward. Synstar will be announcing its interim results for the six months ended 31 March 2003 on Friday 30 May 2003. For further information please contact: Steve Vaughan/Stephen Gleadle Synstar Plc Tel: 01344 662700 Edward Bridges / James Melville-Ross / Juliet Clarke Financial Dynamics Tel: 020 7831 3113 This information is provided by RNS The company news service from the London Stock Exchange END TSTDVLFLXXBBBBZ
1 Year Synthetic Biologics Chart |
1 Month Synthetic Biologics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions